Monarch Capital Management’s Amgen AMGN Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q3
$308K Hold
730
– – 0.07% 118
2026
Q2
$264K Sell
730
-30
-4% -$10.3K 0.06% 122
2026
Q1
$267K Hold
760
– – 0.07% 118
2025
Q4
$249K Hold
760
– – 0.06% 117
2025
Q3
$214K Hold
760
– – 0.05% 120
2025
Q2
$212K Hold
760
– – 0.06% 114
2025
Q1
$237K Buy
+760
New +$224K 0.07% 109
2024
Q4
– Sell
-760
Closed -$245K – 115
2024
Q3
$245K Buy
760
+50
+7% +$16.4K 0.07% 111
2024
Q2
$222K Hold
710
– – 0.07% 110
2024
Q1
$202K Hold
710
– – 0.06% 115
2023
Q4
$204K Buy
+710
New +$193K 0.06% 110

Other funds holding AMGN

Monarch Capital Management's AMGN Position: Q3 2026 in Review

Monarch Capital Management held its Amgen (AMGN) position steady in Q3 2026 at 730 shares worth $308K. The position accounts for 0.07% of the portfolio, ranked #118.

Monarch Capital Management first reported a position in AMGN in Q4 2023 and has held it in 11 quarters since. 2,911 funds tracked by Wall St. Rank hold AMGN as of Q3 2026.

  • Monarch Capital Management held 730 shares of Amgen worth $308K as of Q3 2026.
  • Monarch Capital Management left its Amgen share count unchanged in Q3 2026.
  • Amgen made up 0.07% of Monarch Capital Management's portfolio in Q3 2026, its #118 holding.
  • Monarch Capital Management first reported a position in Amgen in Q4 2023 and has held it in 11 quarters since.
  • 2,911 funds tracked by Wall St. Rank held Amgen as of Q3 2026.

Based on Monarch Capital Management's 13F filing for Q3 2026, filed 19 Oct 2026.